{"entity":{"type":"insider","cik":"0001682115","url":"/insider/0001682115","json_url":"/insider/0001682115.json","name":"OrbiMed Capital GP VI LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":200,"n_filings":83,"first":"2017-04-27","last":"2026-04-23","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP VI LLC","source":"filing","n_filings":83,"first_seen":"2017-04-27","last_seen":"2026-04-23"}],"transactions":[{"id":5761228,"accession":"0000947871-26-000461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000461","line_url":"/filing/0000947871-26-000461#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1689189.0,"shares_display":"1,689,189","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":7499999.16,"total_display":"7,499,999.16","shares_owned_after":11808945.0,"shares_owned_after_display":"11,808,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-23","scope":"insider"},{"id":5761227,"accession":"0000947871-26-000461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000461","line_url":"/filing/0000947871-26-000461#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1126126.0,"shares_display":"1,126,126","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":4999999.44,"total_display":"4,999,999.44","shares_owned_after":1126126.0,"shares_owned_after_display":"1,126,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-23","scope":"insider"},{"id":5901684,"accession":"0000947871-26-000421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40416.0,"shares_display":"40,416","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":263512.32,"total_display":"263,512.32","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider"},{"id":5901682,"accession":"0000947871-26-000421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32523.0,"shares_display":"32,523","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":204569.67,"total_display":"204,569.67","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider"},{"id":5901680,"accession":"0000947871-26-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29319.0,"shares_display":"29,319","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":191453.07,"total_display":"191,453.07","shares_owned_after":34923.0,"shares_owned_after_display":"34,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider"},{"id":5901679,"accession":"0000947871-26-000421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":15312.0,"total_display":"15,312.00","shares_owned_after":32523.0,"shares_owned_after_display":"32,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider"},{"id":4523966,"accession":"0000947871-25-000898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500000.0,"shares_display":"3,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","shares_owned_after":4490254.0,"shares_owned_after_display":"4,490,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4523961,"accession":"0000947871-25-000898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":9026359.0,"shares_owned_after_display":"9,026,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":5105954,"accession":"0000947871-25-000548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000548","line_url":"/filing/0000947871-25-000548#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"NeuroPace Inc","issuer_ticker":"NPCE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134136.0,"shares_display":"134,136","price_per_share":15.83,"price_display":"15.83","price_state":"stated","total_value":2123372.88,"total_display":"2,123,372.88","shares_owned_after":3272199.0,"shares_owned_after_display":"3,272,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-16","scope":"insider"},{"id":5105949,"accession":"0000947871-25-000548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000548","line_url":"/filing/0000947871-25-000548#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"NeuroPace Inc","issuer_ticker":"NPCE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34000.0,"shares_display":"34,000","price_per_share":15.94,"price_display":"15.94","price_state":"stated","total_value":541960.0,"total_display":"541,960.00","shares_owned_after":3238199.0,"shares_owned_after_display":"3,238,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-16","scope":"insider"},{"id":5022638,"accession":"0000947871-25-000384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000384","line_url":"/filing/0000947871-25-000384#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3571428.0,"shares_display":"3,571,428","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":5678570.52,"total_display":"5,678,570.52","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider"},{"id":4193178,"accession":"0000947871-25-000359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000359","line_url":"/filing/0000947871-25-000359#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372578.0,"shares_display":"372,578","price_per_share":20.13,"price_display":"20.13","price_state":"stated","total_value":7499995.14,"total_display":"7,499,995.14","shares_owned_after":14809075.0,"shares_owned_after_display":"14,809,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4193174,"accession":"0000947871-25-000359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000359","line_url":"/filing/0000947871-25-000359#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124193.0,"shares_display":"124,193","price_per_share":20.13,"price_display":"20.13","price_state":"stated","total_value":2500005.09,"total_display":"2,500,005.09","shares_owned_after":443792.0,"shares_owned_after_display":"443,792","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4453815,"accession":"0000947871-25-000345","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3026.0,"shares_display":"3,026","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":163736.86,"total_display":"163,736.86","shares_owned_after":746171.0,"shares_owned_after_display":"746,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453810,"accession":"0000947871-25-000345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1956.0,"shares_display":"1,956","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":105839.16,"total_display":"105,839.16","shares_owned_after":482308.0,"shares_owned_after_display":"482,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453802,"accession":"0000947871-25-000345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":756.0,"shares_display":"756","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":40907.16,"total_display":"40,907.16","shares_owned_after":186541.0,"shares_owned_after_display":"186,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453796,"accession":"0000947871-25-000333","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-9","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5279.0,"shares_display":"5,279","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":285066.0,"total_display":"285,066.00","shares_owned_after":749197.0,"shares_owned_after_display":"749,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453791,"accession":"0000947871-25-000333","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-8","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3412.0,"shares_display":"3,412","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":184248.0,"total_display":"184,248.00","shares_owned_after":484264.0,"shares_owned_after_display":"484,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453782,"accession":"0000947871-25-000333","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-7","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1320.0,"shares_display":"1,320","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":71280.0,"total_display":"71,280.00","shares_owned_after":187297.0,"shares_owned_after_display":"187,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453776,"accession":"0000947871-25-000333","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-6","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":78692.57,"total_display":"78,692.57","shares_owned_after":754476.0,"shares_owned_after_display":"754,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453768,"accession":"0000947871-25-000333","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-5","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":941.0,"shares_display":"941","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":50823.41,"total_display":"50,823.41","shares_owned_after":487676.0,"shares_owned_after_display":"487,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453762,"accession":"0000947871-25-000333","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364.0,"shares_display":"364","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":19659.64,"total_display":"19,659.64","shares_owned_after":188617.0,"shares_owned_after_display":"188,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453743,"accession":"0000947871-25-000333","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20911.0,"shares_display":"20,911","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":1129612.22,"total_display":"1,129,612.22","shares_owned_after":755933.0,"shares_owned_after_display":"755,933","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4453735,"accession":"0000947871-25-000333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13517.0,"shares_display":"13,517","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":730188.34,"total_display":"730,188.34","shares_owned_after":488617.0,"shares_owned_after_display":"488,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4453728,"accession":"0000947871-25-000333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5228.0,"shares_display":"5,228","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":282416.56,"total_display":"282,416.56","shares_owned_after":188981.0,"shares_owned_after_display":"188,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4699253,"accession":"0000947871-25-000308","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-15","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42930.0,"shares_display":"42,930","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":2337109.2,"total_display":"2,337,109.20","shares_owned_after":776844.0,"shares_owned_after_display":"776,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699248,"accession":"0000947871-25-000308","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-14","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27750.0,"shares_display":"27,750","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":1510710.0,"total_display":"1,510,710.00","shares_owned_after":502134.0,"shares_owned_after_display":"502,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699241,"accession":"0000947871-25-000308","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-13","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10733.0,"shares_display":"10,733","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":584304.52,"total_display":"584,304.52","shares_owned_after":194209.0,"shares_owned_after_display":"194,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699234,"accession":"0000947871-25-000308","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-12","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":933.0,"shares_display":"933","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":51361.65,"total_display":"51,361.65","shares_owned_after":819774.0,"shares_owned_after_display":"819,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699230,"accession":"0000947871-25-000308","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-11","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":603.0,"shares_display":"603","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":33195.15,"total_display":"33,195.15","shares_owned_after":529884.0,"shares_owned_after_display":"529,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699223,"accession":"0000947871-25-000308","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-10","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":12826.65,"total_display":"12,826.65","shares_owned_after":204942.0,"shares_owned_after_display":"204,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699220,"accession":"0000947871-25-000308","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-9","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14267.0,"shares_display":"14,267","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":770560.67,"total_display":"770,560.67","shares_owned_after":820707.0,"shares_owned_after_display":"820,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699213,"accession":"0000947871-25-000308","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-8","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9222.0,"shares_display":"9,222","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":498080.22,"total_display":"498,080.22","shares_owned_after":530487.0,"shares_owned_after_display":"530,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699206,"accession":"0000947871-25-000308","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-7","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3567.0,"shares_display":"3,567","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":192653.67,"total_display":"192,653.67","shares_owned_after":205175.0,"shares_owned_after_display":"205,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699199,"accession":"0000947871-25-000308","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-6","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106384.0,"shares_display":"106,384","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":5775587.36,"total_display":"5,775,587.36","shares_owned_after":835185.0,"shares_owned_after_display":"835,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699194,"accession":"0000947871-25-000308","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-5","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68766.0,"shares_display":"68,766","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":3733306.14,"total_display":"3,733,306.14","shares_owned_after":539845.0,"shares_owned_after_display":"539,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699189,"accession":"0000947871-25-000308","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26596.0,"shares_display":"26,596","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":1443896.84,"total_display":"1,443,896.84","shares_owned_after":208795.0,"shares_owned_after_display":"208,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699181,"accession":"0000947871-25-000308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211.0,"shares_display":"211","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":11607.11,"total_display":"11,607.11","shares_owned_after":834974.0,"shares_owned_after_display":"834,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699174,"accession":"0000947871-25-000308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":7481.36,"total_display":"7,481.36","shares_owned_after":539709.0,"shares_owned_after_display":"539,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699168,"accession":"0000947871-25-000308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":2915.53,"total_display":"2,915.53","shares_owned_after":208742.0,"shares_owned_after_display":"208,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":2501118,"accession":"0000947871-24-000728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000728","line_url":"/filing/0000947871-24-000728#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED CAPITAL LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83695.0,"shares_display":"83,695","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":1088035.0,"total_display":"1,088,035.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2580208,"accession":"0000947871-24-000720","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-24-000720","line_url":"/filing/0000947871-24-000720#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69500.0,"shares_display":"69,500","price_per_share":13.03,"price_display":"13.03","price_state":"stated","total_value":905585.0,"total_display":"905,585.00","shares_owned_after":83695.0,"shares_owned_after_display":"83,695","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-23","scope":"insider"},{"id":2580200,"accession":"0000947871-24-000720","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000720","line_url":"/filing/0000947871-24-000720#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":391482.0,"shares_display":"391,482","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":5065777.08,"total_display":"5,065,777.08","shares_owned_after":153195.0,"shares_owned_after_display":"153,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-23","scope":"insider"},{"id":2580197,"accession":"0000947871-24-000720","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000720","line_url":"/filing/0000947871-24-000720#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":394400.0,"shares_display":"394,400","price_per_share":13.52,"price_display":"13.52","price_state":"stated","total_value":5332288.0,"total_display":"5,332,288.00","shares_owned_after":557977.0,"shares_owned_after_display":"557,977","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider"},{"id":2580191,"accession":"0000947871-24-000720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000720","line_url":"/filing/0000947871-24-000720#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13300.0,"shares_display":"13,300","price_per_share":14.61,"price_display":"14.61","price_state":"stated","total_value":194313.0,"total_display":"194,313.00","shares_owned_after":544677.0,"shares_owned_after_display":"544,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider"},{"id":2202168,"accession":"0000947871-24-000701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000701","line_url":"/filing/0000947871-24-000701#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"scPharmaceuticals Inc.","issuer_ticker":"SCPH","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":478342.0,"shares_display":"478,342","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1913368.0,"total_display":"1,913,368.00","shares_owned_after":5806670.0,"shares_owned_after_display":"5,806,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":2202165,"accession":"0000947871-24-000701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000701","line_url":"/filing/0000947871-24-000701#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"scPharmaceuticals Inc.","issuer_ticker":"SCPH","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21658.0,"shares_display":"21,658","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":86632.0,"total_display":"86,632.00","shares_owned_after":252858.0,"shares_owned_after_display":"252,858","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":2672467,"accession":"0000947871-24-000573","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000573","line_url":"/filing/0000947871-24-000573#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43944.0,"shares_display":"43,944","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":1581984.0,"total_display":"1,581,984.00","shares_owned_after":941569.0,"shares_owned_after_display":"941,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2672462,"accession":"0000947871-24-000573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000573","line_url":"/filing/0000947871-24-000573#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28404.0,"shares_display":"28,404","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":1022544.0,"total_display":"1,022,544.00","shares_owned_after":608611.0,"shares_owned_after_display":"608,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2672456,"accession":"0000947871-24-000573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000573","line_url":"/filing/0000947871-24-000573#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10986.0,"shares_display":"10,986","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":395496.0,"total_display":"395,496.00","shares_owned_after":235391.0,"shares_owned_after_display":"235,391","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"}],"next_cursor":"2024-06-17|2672456","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001678660","name":"Prelude Therapeutics Inc","url":"/issuer/0001678660","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2020-09-29","last_seen":"2026-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2018-01-30","last_seen":"2026-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001528287","name":"NeuroPace Inc","url":"/issuer/0001528287","role":"Ten percent owner","n_filings":8,"first_seen":"2021-04-23","last_seen":"2025-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001738021","name":"Compass Therapeutics, Inc.","url":"/issuer/0001738021","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2025-04-11","last_seen":"2025-04-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-03-31","last_seen":"2025-04-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2023-02-17","last_seen":"2025-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-12-08","last_seen":"2024-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001604950","name":"scPharmaceuticals Inc.","url":"/issuer/0001604950","role":"Ten percent owner","n_filings":4,"first_seen":"2017-11-21","last_seen":"2024-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2019-01-23","last_seen":"2023-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001764974","name":"Turnstone Biologics Corp.","url":"/issuer/0001764974","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2023-07-24","last_seen":"2023-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001657312","name":"Verona Pharma plc","url":"/issuer/0001657312","role":"Director","n_filings":2,"first_seen":"2022-12-27","last_seen":"2023-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Ten percent owner","n_filings":9,"first_seen":"2019-09-19","last_seen":"2022-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001835579","name":"Ikena Oncology, Inc.","url":"/issuer/0001835579","role":"Director","n_filings":3,"first_seen":"2021-04-01","last_seen":"2022-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2019-11-13","last_seen":"2022-01-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001796280","name":"Oric Pharmaceuticals, Inc.","url":"/issuer/0001796280","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2020-04-28","last_seen":"2021-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0000891293","name":"CTI BIOPHARMA CORP","url":"/issuer/0000891293","role":"Ten percent owner","n_filings":1,"first_seen":"2021-01-11","last_seen":"2021-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001664106","name":"LogicBio Therapeutics, Inc.","url":"/issuer/0001664106","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-10-25","last_seen":"2020-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001534133","name":"GRAYBUG VISION, INC.","url":"/issuer/0001534133","role":"Ten percent owner","n_filings":1,"first_seen":"2020-09-29","last_seen":"2020-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001714798","name":"Prevail Therapeutics Inc.","url":"/issuer/0001714798","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2019-06-26","last_seen":"2019-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001661059","name":"NextCure, Inc.","url":"/issuer/0001661059","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2019-05-13","last_seen":"2019-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Director","n_filings":1,"first_seen":"2019-04-24","last_seen":"2019-04-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001619087","name":"SteadyMed Ltd.","url":"/issuer/0001619087","role":"Ten percent owner","n_filings":2,"first_seen":"2017-04-27","last_seen":"2018-09-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-24","last_seen":"2018-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"Kala Pharmaceuticals, Inc.","url":"/issuer/0001479419","role":"Ten percent owner, Other","n_filings":7,"first_seen":"2017-07-27","last_seen":"2018-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682115","retrieved_at":"2026-08-21T21:54:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}